nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CYP2A6—Fluorouracil—colon cancer	0.0571	1	CbGbCtD
Fomepizole—CAT—endothelium—colon cancer	0.0489	0.0882	CbGeAlD
Fomepizole—CAT—blood vessel—colon cancer	0.0451	0.0814	CbGeAlD
Fomepizole—ADH1B—blood vessel—colon cancer	0.0406	0.0733	CbGeAlD
Fomepizole—ADH1B—gall bladder—colon cancer	0.0382	0.0689	CbGeAlD
Fomepizole—CAT—embryo—colon cancer	0.0269	0.0485	CbGeAlD
Fomepizole—ADH1A—Abacavir transport and metabolism—ABCB1—colon cancer	0.0269	0.168	CbGpPWpGaD
Fomepizole—CAT—epithelium—colon cancer	0.022	0.0396	CbGeAlD
Fomepizole—ADH1A—digestive system—colon cancer	0.0217	0.0391	CbGeAlD
Fomepizole—CAT—smooth muscle tissue—colon cancer	0.0212	0.0382	CbGeAlD
Fomepizole—CAT—Vinorelbine—Vincristine—colon cancer	0.0206	0.593	CbGdCrCtD
Fomepizole—CAT—renal system—colon cancer	0.0204	0.0367	CbGeAlD
Fomepizole—ADH1C—vagina—colon cancer	0.0188	0.0339	CbGeAlD
Fomepizole—ADH1B—renal system—colon cancer	0.0183	0.0331	CbGeAlD
Fomepizole—CAT—lymphoid tissue—colon cancer	0.0169	0.0305	CbGeAlD
Fomepizole—CAT—digestive system—colon cancer	0.0167	0.0301	CbGeAlD
Fomepizole—ADH1A—liver—colon cancer	0.0162	0.0292	CbGeAlD
Fomepizole—ADH1C—liver—colon cancer	0.0159	0.0286	CbGeAlD
Fomepizole—CAT—bone marrow—colon cancer	0.0154	0.0278	CbGeAlD
Fomepizole—ADH1B—lymphoid tissue—colon cancer	0.0152	0.0275	CbGeAlD
Fomepizole—ADH1B—digestive system—colon cancer	0.015	0.0271	CbGeAlD
Fomepizole—CAT—vagina—colon cancer	0.0147	0.0266	CbGeAlD
Fomepizole—CAT—Vinblastine—Vincristine—colon cancer	0.0142	0.407	CbGdCrCtD
Fomepizole—ADH1B—vagina—colon cancer	0.0133	0.024	CbGeAlD
Fomepizole—CAT—liver—colon cancer	0.0124	0.0224	CbGeAlD
Fomepizole—ADH1A—lymph node—colon cancer	0.0124	0.0224	CbGeAlD
Fomepizole—ADH1C—lymph node—colon cancer	0.0122	0.0219	CbGeAlD
Fomepizole—ADH1B—liver—colon cancer	0.0112	0.0202	CbGeAlD
Fomepizole—Application site reaction—Fluorouracil—colon cancer	0.00958	0.0495	CcSEcCtD
Fomepizole—CAT—lymph node—colon cancer	0.00954	0.0172	CbGeAlD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—BAX—colon cancer	0.00949	0.0592	CbGpPWpGaD
Fomepizole—ADH1B—lymph node—colon cancer	0.00859	0.0155	CbGeAlD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—BCL2L1—colon cancer	0.00824	0.0514	CbGpPWpGaD
Fomepizole—Taste metallic—Methotrexate—colon cancer	0.00735	0.038	CcSEcCtD
Fomepizole—Nystagmus—Vincristine—colon cancer	0.00675	0.0349	CcSEcCtD
Fomepizole—CYP2A6—vagina—colon cancer	0.00671	0.0121	CbGeAlD
Fomepizole—Anuria—Methotrexate—colon cancer	0.00669	0.0346	CcSEcCtD
Fomepizole—Heartburn—Fluorouracil—colon cancer	0.00653	0.0338	CcSEcCtD
Fomepizole—Nystagmus—Fluorouracil—colon cancer	0.00629	0.0325	CcSEcCtD
Fomepizole—CYP2A6—liver—colon cancer	0.00566	0.0102	CbGeAlD
Fomepizole—CAT—Nucleotide metabolism—TYMS—colon cancer	0.00554	0.0346	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—CASP3—colon cancer	0.0051	0.0318	CbGpPWpGaD
Fomepizole—Hiccups—Irinotecan—colon cancer	0.00469	0.0243	CcSEcCtD
Fomepizole—CYP2E1—renal system—colon cancer	0.00438	0.00789	CbGeAlD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—BAX—colon cancer	0.00409	0.0255	CbGpPWpGaD
Fomepizole—CAT—FoxO family signaling—CTNNB1—colon cancer	0.00401	0.025	CbGpPWpGaD
Fomepizole—CAT—FoxO family signaling—EP300—colon cancer	0.00373	0.0233	CbGpPWpGaD
Fomepizole—CYP2E1—lymphoid tissue—colon cancer	0.00363	0.00655	CbGeAlD
Fomepizole—Visual disturbance—Irinotecan—colon cancer	0.00359	0.0186	CcSEcCtD
Fomepizole—CYP2E1—digestive system—colon cancer	0.00359	0.00647	CbGeAlD
Fomepizole—ADH1C—Metabolism—CA7—colon cancer	0.00356	0.0222	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CA7—colon cancer	0.00356	0.0222	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CHST4—colon cancer	0.00344	0.0215	CbGpPWpGaD
Fomepizole—CAT—Amyotrophic lateral sclerosis (ALS)—TP53—colon cancer	0.00327	0.0204	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CA7—colon cancer	0.0032	0.02	CbGpPWpGaD
Fomepizole—Hiccups—Capecitabine—colon cancer	0.00314	0.0162	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—APC—colon cancer	0.00311	0.0194	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—CA7—colon cancer	0.00295	0.0184	CbGpPWpGaD
Fomepizole—CAT—Selenium Micronutrient Network—PTGS2—colon cancer	0.00281	0.0175	CbGpPWpGaD
Fomepizole—Eosinophilia—Fluorouracil—colon cancer	0.00279	0.0144	CcSEcCtD
Fomepizole—CYP2E1—liver—colon cancer	0.00267	0.00482	CbGeAlD
Fomepizole—Phlebitis—Capecitabine—colon cancer	0.00265	0.0137	CcSEcCtD
Fomepizole—Bradycardia—Irinotecan—colon cancer	0.0024	0.0124	CcSEcCtD
Fomepizole—Visual impairment—Irinotecan—colon cancer	0.00227	0.0117	CcSEcCtD
Fomepizole—CAT—FoxO family signaling—AKT1—colon cancer	0.00225	0.0141	CbGpPWpGaD
Fomepizole—Pharyngitis—Fluorouracil—colon cancer	0.00224	0.0116	CcSEcCtD
Fomepizole—Flushing—Irinotecan—colon cancer	0.00219	0.0113	CcSEcCtD
Fomepizole—ADH1C—Metabolism—ODC1—colon cancer	0.00216	0.0134	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—CHST5—colon cancer	0.00216	0.0134	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—CHST5—colon cancer	0.00216	0.0134	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ODC1—colon cancer	0.00216	0.0134	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CCND1—colon cancer	0.00214	0.0133	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CTNNB1—colon cancer	0.00212	0.0132	CbGpPWpGaD
Fomepizole—CAT—Folate Metabolism—TP53—colon cancer	0.0021	0.0131	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—CDKN1A—colon cancer	0.00207	0.0129	CbGpPWpGaD
Fomepizole—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00206	0.0128	CbGpPWpGaD
Fomepizole—Back pain—Vincristine—colon cancer	0.00204	0.0105	CcSEcCtD
Fomepizole—Back pain—Irinotecan—colon cancer	0.00198	0.0103	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TYMS—colon cancer	0.00197	0.0123	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—colon cancer	0.00196	0.0122	CbGpPWpGaD
Fomepizole—Anaemia—Vincristine—colon cancer	0.00195	0.0101	CcSEcCtD
Fomepizole—CAT—Metabolism—ODC1—colon cancer	0.00194	0.0121	CbGpPWpGaD
Fomepizole—CAT—Metabolism—CHST5—colon cancer	0.00194	0.0121	CbGpPWpGaD
Fomepizole—Agitation—Vincristine—colon cancer	0.00194	0.01	CcSEcCtD
Fomepizole—Anaemia—Irinotecan—colon cancer	0.0019	0.0098	CcSEcCtD
Fomepizole—Vertigo—Vincristine—colon cancer	0.00189	0.00978	CcSEcCtD
Fomepizole—Vision blurred—Fluorouracil—colon cancer	0.00185	0.00957	CcSEcCtD
Fomepizole—Vertigo—Irinotecan—colon cancer	0.00184	0.00953	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—NRAS—colon cancer	0.00184	0.0115	CbGpPWpGaD
Fomepizole—Convulsion—Vincristine—colon cancer	0.00182	0.00943	CcSEcCtD
Fomepizole—Anaemia—Fluorouracil—colon cancer	0.00182	0.00938	CcSEcCtD
Fomepizole—Visual disturbance—Methotrexate—colon cancer	0.00179	0.00926	CcSEcCtD
Fomepizole—ADH1A—Metabolism—CHST5—colon cancer	0.00179	0.0111	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—ODC1—colon cancer	0.00179	0.0111	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—MYC—colon cancer	0.00171	0.0107	CbGpPWpGaD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TGFB1—colon cancer	0.00171	0.0107	CbGpPWpGaD
Fomepizole—Convulsion—Fluorouracil—colon cancer	0.0017	0.0088	CcSEcCtD
Fomepizole—Shock—Irinotecan—colon cancer	0.00165	0.00851	CcSEcCtD
Fomepizole—Hypotension—Vincristine—colon cancer	0.00161	0.0083	CcSEcCtD
Fomepizole—Bradycardia—Capecitabine—colon cancer	0.00161	0.0083	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—KRAS—colon cancer	0.00158	0.00988	CbGpPWpGaD
Fomepizole—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	0.00158	0.00985	CbGpPWpGaD
Fomepizole—Pharyngitis—Capecitabine—colon cancer	0.00157	0.00809	CcSEcCtD
Fomepizole—Tachycardia—Fluorouracil—colon cancer	0.00156	0.00809	CcSEcCtD
Fomepizole—Hypotension—Irinotecan—colon cancer	0.00156	0.00809	CcSEcCtD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00155	0.00965	CbGpPWpGaD
Fomepizole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—colon cancer	0.00154	0.00962	CbGpPWpGaD
Fomepizole—Visual impairment—Capecitabine—colon cancer	0.00152	0.00786	CcSEcCtD
Fomepizole—Hypotension—Fluorouracil—colon cancer	0.0015	0.00774	CcSEcCtD
Fomepizole—Decreased appetite—Vincristine—colon cancer	0.00149	0.00772	CcSEcCtD
Fomepizole—Somnolence—Irinotecan—colon cancer	0.00149	0.00769	CcSEcCtD
Fomepizole—Dyspepsia—Irinotecan—colon cancer	0.00147	0.00762	CcSEcCtD
Fomepizole—Pain—Vincristine—colon cancer	0.00147	0.0076	CcSEcCtD
Fomepizole—Flushing—Capecitabine—colon cancer	0.00146	0.00756	CcSEcCtD
Fomepizole—Decreased appetite—Irinotecan—colon cancer	0.00146	0.00752	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—PIK3CA—colon cancer	0.00145	0.00907	CbGpPWpGaD
Fomepizole—Eosinophilia—Methotrexate—colon cancer	0.00145	0.00751	CcSEcCtD
Fomepizole—Pain—Irinotecan—colon cancer	0.00143	0.0074	CcSEcCtD
Fomepizole—Somnolence—Fluorouracil—colon cancer	0.00143	0.00737	CcSEcCtD
Fomepizole—Dyspepsia—Fluorouracil—colon cancer	0.00141	0.00729	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—TP53—colon cancer	0.00141	0.00878	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Vincristine—colon cancer	0.00141	0.00727	CcSEcCtD
Fomepizole—Decreased appetite—Fluorouracil—colon cancer	0.00139	0.0072	CcSEcCtD
Fomepizole—Pain—Fluorouracil—colon cancer	0.00137	0.00709	CcSEcCtD
Fomepizole—Gastrointestinal pain—Irinotecan—colon cancer	0.00137	0.00708	CcSEcCtD
Fomepizole—Abdominal pain—Vincristine—colon cancer	0.00136	0.00702	CcSEcCtD
Fomepizole—Body temperature increased—Vincristine—colon cancer	0.00136	0.00702	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—HRAS—colon cancer	0.00135	0.0084	CbGpPWpGaD
Fomepizole—Dysgeusia—Capecitabine—colon cancer	0.00134	0.00695	CcSEcCtD
Fomepizole—Back pain—Capecitabine—colon cancer	0.00133	0.00686	CcSEcCtD
Fomepizole—Abdominal pain—Irinotecan—colon cancer	0.00132	0.00684	CcSEcCtD
Fomepizole—Body temperature increased—Irinotecan—colon cancer	0.00132	0.00684	CcSEcCtD
Fomepizole—Drowsiness—Methotrexate—colon cancer	0.00131	0.00676	CcSEcCtD
Fomepizole—Vision blurred—Capecitabine—colon cancer	0.00129	0.00669	CcSEcCtD
Fomepizole—Anaemia—Capecitabine—colon cancer	0.00127	0.00656	CcSEcCtD
Fomepizole—Body temperature increased—Fluorouracil—colon cancer	0.00127	0.00655	CcSEcCtD
Fomepizole—Vertigo—Capecitabine—colon cancer	0.00123	0.00637	CcSEcCtD
Fomepizole—CAT—DNA Damage Response (only ATM dependent)—AKT1—colon cancer	0.00119	0.00741	CbGpPWpGaD
Fomepizole—Diarrhoea—Vincristine—colon cancer	0.00118	0.00608	CcSEcCtD
Fomepizole—Pharyngitis—Methotrexate—colon cancer	0.00117	0.00602	CcSEcCtD
Fomepizole—Anxiety—Capecitabine—colon cancer	0.00116	0.00602	CcSEcCtD
Fomepizole—Diarrhoea—Irinotecan—colon cancer	0.00115	0.00592	CcSEcCtD
Fomepizole—Dizziness—Vincristine—colon cancer	0.00114	0.00588	CcSEcCtD
Fomepizole—Visual impairment—Methotrexate—colon cancer	0.00113	0.00585	CcSEcCtD
Fomepizole—Dizziness—Irinotecan—colon cancer	0.00111	0.00572	CcSEcCtD
Fomepizole—Shock—Capecitabine—colon cancer	0.0011	0.0057	CcSEcCtD
Fomepizole—Diarrhoea—Fluorouracil—colon cancer	0.0011	0.00567	CcSEcCtD
Fomepizole—Tachycardia—Capecitabine—colon cancer	0.00109	0.00565	CcSEcCtD
Fomepizole—Vomiting—Vincristine—colon cancer	0.00109	0.00565	CcSEcCtD
Fomepizole—Rash—Vincristine—colon cancer	0.00108	0.0056	CcSEcCtD
Fomepizole—Dermatitis—Vincristine—colon cancer	0.00108	0.0056	CcSEcCtD
Fomepizole—Headache—Vincristine—colon cancer	0.00108	0.00557	CcSEcCtD
Fomepizole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00108	0.00672	CbGpPWpGaD
Fomepizole—Vomiting—Irinotecan—colon cancer	0.00106	0.0055	CcSEcCtD
Fomepizole—Dizziness—Fluorouracil—colon cancer	0.00106	0.00548	CcSEcCtD
Fomepizole—Rash—Irinotecan—colon cancer	0.00106	0.00546	CcSEcCtD
Fomepizole—Dermatitis—Irinotecan—colon cancer	0.00105	0.00545	CcSEcCtD
Fomepizole—Headache—Irinotecan—colon cancer	0.00105	0.00542	CcSEcCtD
Fomepizole—Hypotension—Capecitabine—colon cancer	0.00105	0.00541	CcSEcCtD
Fomepizole—Nausea—Vincristine—colon cancer	0.00102	0.00528	CcSEcCtD
Fomepizole—Vomiting—Fluorouracil—colon cancer	0.00102	0.00527	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—CDKN1A—colon cancer	0.00102	0.00635	CbGpPWpGaD
Fomepizole—Rash—Fluorouracil—colon cancer	0.00101	0.00523	CcSEcCtD
Fomepizole—Dermatitis—Fluorouracil—colon cancer	0.00101	0.00522	CcSEcCtD
Fomepizole—Headache—Fluorouracil—colon cancer	0.001	0.00519	CcSEcCtD
Fomepizole—Dysgeusia—Methotrexate—colon cancer	0.001	0.00517	CcSEcCtD
Fomepizole—Nausea—Irinotecan—colon cancer	0.000994	0.00514	CcSEcCtD
Fomepizole—Back pain—Methotrexate—colon cancer	0.000989	0.00511	CcSEcCtD
Fomepizole—Dyspepsia—Capecitabine—colon cancer	0.000986	0.0051	CcSEcCtD
Fomepizole—Decreased appetite—Capecitabine—colon cancer	0.000974	0.00503	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—EP300—colon cancer	0.000969	0.00605	CbGpPWpGaD
Fomepizole—Vision blurred—Methotrexate—colon cancer	0.000963	0.00498	CcSEcCtD
Fomepizole—Pain—Capecitabine—colon cancer	0.000958	0.00495	CcSEcCtD
Fomepizole—Nausea—Fluorouracil—colon cancer	0.000952	0.00492	CcSEcCtD
Fomepizole—Anaemia—Methotrexate—colon cancer	0.000945	0.00488	CcSEcCtD
Fomepizole—Vertigo—Methotrexate—colon cancer	0.000918	0.00475	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—VEGFA—colon cancer	0.000918	0.00573	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Capecitabine—colon cancer	0.000916	0.00474	CcSEcCtD
Fomepizole—Body temperature increased—Capecitabine—colon cancer	0.000886	0.00458	CcSEcCtD
Fomepizole—Abdominal pain—Capecitabine—colon cancer	0.000886	0.00458	CcSEcCtD
Fomepizole—Convulsion—Methotrexate—colon cancer	0.000885	0.00458	CcSEcCtD
Fomepizole—Hypotension—Methotrexate—colon cancer	0.000779	0.00403	CcSEcCtD
Fomepizole—Diarrhoea—Capecitabine—colon cancer	0.000767	0.00396	CcSEcCtD
Fomepizole—Somnolence—Methotrexate—colon cancer	0.000742	0.00383	CcSEcCtD
Fomepizole—Dizziness—Capecitabine—colon cancer	0.000741	0.00383	CcSEcCtD
Fomepizole—Dyspepsia—Methotrexate—colon cancer	0.000734	0.00379	CcSEcCtD
Fomepizole—Decreased appetite—Methotrexate—colon cancer	0.000725	0.00375	CcSEcCtD
Fomepizole—Pain—Methotrexate—colon cancer	0.000713	0.00369	CcSEcCtD
Fomepizole—Vomiting—Capecitabine—colon cancer	0.000712	0.00368	CcSEcCtD
Fomepizole—Rash—Capecitabine—colon cancer	0.000706	0.00365	CcSEcCtD
Fomepizole—Dermatitis—Capecitabine—colon cancer	0.000706	0.00365	CcSEcCtD
Fomepizole—Headache—Capecitabine—colon cancer	0.000702	0.00363	CcSEcCtD
Fomepizole—CAT—Cellular responses to stress—TP53—colon cancer	0.000693	0.00433	CbGpPWpGaD
Fomepizole—Gastrointestinal pain—Methotrexate—colon cancer	0.000682	0.00353	CcSEcCtD
Fomepizole—Nausea—Capecitabine—colon cancer	0.000666	0.00344	CcSEcCtD
Fomepizole—Abdominal pain—Methotrexate—colon cancer	0.000659	0.00341	CcSEcCtD
Fomepizole—Body temperature increased—Methotrexate—colon cancer	0.000659	0.00341	CcSEcCtD
Fomepizole—CYP2A6—Fluoropyrimidine Activity—TP53—colon cancer	0.000653	0.00408	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CA7—colon cancer	0.000572	0.00357	CbGpPWpGaD
Fomepizole—Diarrhoea—Methotrexate—colon cancer	0.000571	0.00295	CcSEcCtD
Fomepizole—ADH1C—Metabolism—ABCB1—colon cancer	0.00057	0.00355	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—ABCB1—colon cancer	0.00057	0.00355	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—TYMS—colon cancer	0.000559	0.00349	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—TYMS—colon cancer	0.000559	0.00349	CbGpPWpGaD
Fomepizole—Dizziness—Methotrexate—colon cancer	0.000552	0.00285	CcSEcCtD
Fomepizole—Vomiting—Methotrexate—colon cancer	0.00053	0.00274	CcSEcCtD
Fomepizole—Rash—Methotrexate—colon cancer	0.000526	0.00272	CcSEcCtD
Fomepizole—Dermatitis—Methotrexate—colon cancer	0.000525	0.00272	CcSEcCtD
Fomepizole—Headache—Methotrexate—colon cancer	0.000523	0.0027	CcSEcCtD
Fomepizole—CAT—Metabolism—ABCB1—colon cancer	0.000513	0.0032	CbGpPWpGaD
Fomepizole—CAT—Metabolism—TYMS—colon cancer	0.000504	0.00314	CbGpPWpGaD
Fomepizole—Nausea—Methotrexate—colon cancer	0.000495	0.00256	CcSEcCtD
Fomepizole—ADH1A—Metabolism—ABCB1—colon cancer	0.000472	0.00294	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—TYMS—colon cancer	0.000464	0.00289	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CA7—colon cancer	0.000452	0.00282	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PPARG—colon cancer	0.000396	0.00247	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PPARG—colon cancer	0.000396	0.00247	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PPARG—colon cancer	0.000357	0.00223	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ODC1—colon cancer	0.000346	0.00216	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—CHST5—colon cancer	0.000346	0.00216	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PPARG—colon cancer	0.000328	0.00205	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PTGS2—colon cancer	0.000312	0.00194	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PTGS2—colon cancer	0.000312	0.00194	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PTGS2—colon cancer	0.000281	0.00175	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ODC1—colon cancer	0.000274	0.00171	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—CHST5—colon cancer	0.000274	0.00171	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—EP300—colon cancer	0.000259	0.00162	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—EP300—colon cancer	0.000259	0.00162	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PTGS2—colon cancer	0.000258	0.00161	CbGpPWpGaD
Fomepizole—CYP2A6—NRF2 pathway—TGFB1—colon cancer	0.000241	0.00151	CbGpPWpGaD
Fomepizole—CAT—Metabolism—EP300—colon cancer	0.000233	0.00146	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—EP300—colon cancer	0.000215	0.00134	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—PIK3CA—colon cancer	0.000192	0.0012	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—PIK3CA—colon cancer	0.000192	0.0012	CbGpPWpGaD
Fomepizole—CAT—Metabolism—PIK3CA—colon cancer	0.000173	0.00108	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—PIK3CA—colon cancer	0.000159	0.000992	CbGpPWpGaD
Fomepizole—ADH1C—Metabolism—AKT1—colon cancer	0.000157	0.000978	CbGpPWpGaD
Fomepizole—ADH1B—Metabolism—AKT1—colon cancer	0.000157	0.000978	CbGpPWpGaD
Fomepizole—CAT—Metabolism—AKT1—colon cancer	0.000141	0.00088	CbGpPWpGaD
Fomepizole—ADH1A—Metabolism—AKT1—colon cancer	0.00013	0.00081	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—ABCB1—colon cancer	9.15e-05	0.000571	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—TYMS—colon cancer	8.99e-05	0.000561	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—ABCB1—colon cancer	7.23e-05	0.000451	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—TYMS—colon cancer	7.1e-05	0.000443	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PPARG—colon cancer	6.37e-05	0.000397	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PPARG—colon cancer	5.03e-05	0.000314	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PTGS2—colon cancer	5.01e-05	0.000313	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—EP300—colon cancer	4.17e-05	0.00026	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PTGS2—colon cancer	3.96e-05	0.000247	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—EP300—colon cancer	3.29e-05	0.000205	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—PIK3CA—colon cancer	3.08e-05	0.000192	CbGpPWpGaD
Fomepizole—CYP2A6—Metabolism—AKT1—colon cancer	2.52e-05	0.000157	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—PIK3CA—colon cancer	2.44e-05	0.000152	CbGpPWpGaD
Fomepizole—CYP2E1—Metabolism—AKT1—colon cancer	1.99e-05	0.000124	CbGpPWpGaD
